<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02128178</url>
  </required_header>
  <id_info>
    <org_study_id>Enoxaparin</org_study_id>
    <nct_id>NCT02128178</nct_id>
  </id_info>
  <brief_title>Laparoscopic Bariatric Surgery: Two Regimens of Venous Thromboprophylaxis: Prospective Randomized Study</brief_title>
  <official_title>Laparoscopic Bariatric Surgery: Two Regimens of Venous Thromboprophylaxis: Prospective Randomized Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mansoura University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Obese patients undergoing bariatric surgery warrant VTE prophylaxis because they are at high
      risk for developing a fatal pulmonary embolism or postthrombotic syndrome. However, a
      consensus does not exist on the most effective prophylactic approach.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Two regimens of prophylaxis are supposed , the 1st one is to give enoxaparin 40mg 2 hours
      before surgery and continued daily for 10 days after, and the 2nd one is to start 12 hours
      before surgery and continued in the same way like the 1st one.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2013</start_date>
  <completion_date type="Anticipated">May 2016</completion_date>
  <primary_completion_date type="Anticipated">April 2016</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Venous thrombosis and/or pulmonary embolism (PE)</measure>
    <time_frame>Postoperative 4 weeks</time_frame>
    <description>To assess the venous thrombosis by compression ultrasonography and PE in suspected patients</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Bleeding from the surgery site , drain if any, GIT bleeding,</measure>
    <time_frame>postoperative 4 weeks</time_frame>
    <description>Bleeding from drain, GIT, or wounds are assessed clinically</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hospital stay</measure>
    <time_frame>4 WEEKS</time_frame>
    <description>hospital stay in days</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">700</enrollment>
  <condition>Morbid Obesity</condition>
  <condition>Pulmonary Embolism</condition>
  <arm_group>
    <arm_group_label>ENOXAPARIN 2 HOURS BEFORE</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Giving 40 mg enoxaparin SQ 2 hours before surgery and daily for 10 days thereafter</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Enoxaparin 40 mg 12 hours before</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Enoxaparin 40 mg 12 hours before surgery and once daily for 10 days thereafter</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Enoxaparin 40 mg 2 hours before arm</intervention_name>
    <description>Enoxaparin 40 mg 2 hours before surgery</description>
    <arm_group_label>ENOXAPARIN 2 HOURS BEFORE</arm_group_label>
    <arm_group_label>Enoxaparin 40 mg 12 hours before</arm_group_label>
    <other_name>First group</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Enoxaparin 40 mg 12 hours before arm</intervention_name>
    <description>Enoxaparin 40 mg 12 hours before surgery</description>
    <arm_group_label>ENOXAPARIN 2 HOURS BEFORE</arm_group_label>
    <arm_group_label>Enoxaparin 40 mg 12 hours before</arm_group_label>
    <other_name>second group</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BMI &gt;40 OR &gt;35 with comorbidities

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>mohamed e abd ellatif, phd</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mansoura University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>mohamed e abd ellatif, phd</last_name>
    <email>surg_latif@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Manoura University</name>
      <address>
        <city>Mansoura</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>mohamed e abd ellatif, phd</last_name>
      <email>surg_latif@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>mohamed e abd ellatif, phd</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 22, 2014</study_first_submitted>
  <study_first_submitted_qc>April 30, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 1, 2014</study_first_posted>
  <last_update_submitted>April 7, 2015</last_update_submitted>
  <last_update_submitted_qc>April 7, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 8, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mansoura University</investigator_affiliation>
    <investigator_full_name>MOHAMED ABDELLATIF</investigator_full_name>
    <investigator_title>phd</investigator_title>
  </responsible_party>
  <keyword>Morbid obesity</keyword>
  <keyword>Laparoscopic surgery</keyword>
  <keyword>Compression ultrasonography</keyword>
  <keyword>Pulmonary embolism</keyword>
  <keyword>Bleeding</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Embolism</mesh_term>
    <mesh_term>Pulmonary Embolism</mesh_term>
    <mesh_term>Obesity, Morbid</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

